Literature DB >> 6414084

Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma.

A ar-Rushdi, K Nishikura, J Erikson, R Watt, G Rovera, C M Croce.   

Abstract

Burkitt lymphoma cells carrying either a rearranged or unrearranged c-myc oncogene were examined with the use of probes from the 5' exon and for the second and third exon of the oncogene. The results indicate that the normal c-myc gene on chromosome 8 and the 5' noncoding and 3' coding segments of the c-myc oncogene separated by the chromosomal translocation are under different transcriptional control in the lymphoma cells. Burkitt lymphoma cells carrying a translocated but unrearranged c-myc oncogene express normal c-myc transcripts. In contrast, lymphoma cells carrying a c-myc gene rearranged head to head with the immunoglobulin constant mu region gene express c-myc transcripts lacking the normal untranslated leader.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6414084     DOI: 10.1126/science.6414084

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  105 in total

1.  Expression of the woodchuck N-myc2 retroposon in brain and in liver tumors is driven by a cryptic N-myc promoter.

Authors:  G Fourel; C Transy; B C Tennant; M A Buendia
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

2.  Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA 231 (ER-) breast carcinoma cell line. PRP-1 inhibits mesenchymal tumors.

Authors:  Karina A Galoian; Thomas H Temple; Armen Galoyan
Journal:  Tumour Biol       Date:  2011-04-15

3.  The human Pim-1 gene is selectively transcribed in different hemato-lymphoid cell lines in spite of a G + C-rich housekeeping promoter.

Authors:  T C Meeker; J Loeb; M Ayres; W Sellers
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

4.  Myc: the beauty and the beast.

Authors:  Amanda R Wasylishen; Linda Z Penn
Journal:  Genes Cancer       Date:  2010-06

5.  The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.

Authors:  Monica Cardone; Ayten Kandilci; Cintia Carella; Jonas A Nilsson; Jennifer A Brennan; Sema Sirma; Ugur Ozbek; Kelli Boyd; John L Cleveland; Gerard C Grosveld
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

6.  Accurate and efficient transcription of human c-myc genes injected into Xenopus laevis oocytes.

Authors:  K Nishikura; S Goldflam; G A Vuocolo
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

7.  NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma.

Authors:  L Ji; M Arcinas; L M Boxer
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Molecular cloning of the breakpoint junction of a human chromosomal 8;14 translocation involving the T-cell receptor alpha-chain gene and sequences on the 3' side of MYC.

Authors:  T W McKeithan; E A Shima; M M Le Beau; J Minowada; J D Rowley; M O Diaz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

9.  Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.

Authors:  A G Geiser; C J Der; C J Marshall; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

10.  Translocation and rearrangement of c-myc into immunoglobulin alpha heavy chain locus in primary cells from acute lymphocytic leukemia.

Authors:  C Peschle; F Mavilio; N M Sposi; A Giampaolo; A Caré; L Bottero; M Bruno; G Mastroberardino; R Gastaldi; M G Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.